Spending on Tuberculosis Slipped Last Year

Few diseases need new medicines as much as tuberculosis, with most patients diagnosed by a method more than a century old and treated with drugs more than 40 years old. Yet global investment in new tools declined last year, a new report found.

While the dropin funding wasn’t huge, it comes at a time of a worsening epidemic of drug-resistant TB, which public-health authorities say can’t be confronted effectively without new tools.

Read more…